Selective Janus kinase inhibitors: Promising drugs for rheumatoid arthritis

被引：1
|
作者：
Zanwar, Abhishek [1 ]
Aggarwal, Amita [1 ]
机构：
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India
来源：
NATIONAL MEDICAL JOURNAL OF INDIA | 2019年 / 32卷 / 02期
关键词：
TOFACITINIB; ADALIMUMAB; PLACEBO; SAFETY;
D O I：
10.4103/0970-258X.275350
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：96 / +
页数：2
相关论文
共 50 条
  • [21] Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US
    Alison Walton
    Jim Paik
    Amanda Quebe
    Carol L. Kannowski
    Casey Choong
    Seth Anderson
    Justin K. Owensby
    Rheumatology and Therapy, 2021, 8 : 599 - 607
  • [22] Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US
    Walton, Alison
    Paik, Jim
    Quebe, Amanda
    Kannowski, Carol L.
    Choong, Casey
    Anderson, Seth
    Owensby, Justin K.
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 599 - 607
  • [23] Tofacitinib: The First Janus Kinase (JAK) Inhibitor for the Treatment of Rheumatoid Arthritis
    Vyas, Deepti
    O'Dell, Kate M.
    Bandy, Jason L.
    Boyce, Eric G.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1524 - 1531
  • [24] Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis
    Martinez-Molina, Cristina
    Tey, Jose Maria Guardiola
    Ruiz-Ramos, Jesus
    Feliu, Anna
    Puig-Campmany, Mireia
    Vidal, Silvia
    Corominas, Hector
    MEDICINA CLINICA, 2024, 163 (08): : 391 - 396
  • [25] Janus kinase inhibitors
    Witte, Torsten
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2022, 81 (02): : 94 - 99
  • [26] Tumor necrosis factor inhibitors versus janus kinase inhibitors in patients with incomplete response to methotrexate in rheumatoid arthritis
    Chandwar, Kunal
    Shah, Chandani
    Srivastava, Puja
    INDIAN JOURNAL OF RHEUMATOLOGY, 2023, 18 (01) : 108 - 110
  • [27] Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis
    Iwata, Shigeru
    Tanaka, Yoshiya
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (10) : 1047 - 1057
  • [28] Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
    Hayashi, Shinya
    Tachibana, Shotaro
    Maeda, Toshihisa
    Yamashita, Mai
    Shirasugi, Iku
    Yamamoto, Yuzuru
    Yamada, Hirotaka
    Okano, Takaichi
    Nishimura, Keisuke
    Ueda, Yo
    Jinnno, Sadao
    Saegusa, Jun
    Yamamoto, Wataru
    Murata, Koichi
    Fujii, Takayuki
    Hata, Kenichiro
    Yoshikawa, Ayaka
    Ebina, Kosuke
    Etani, Yuki
    Yoshida, Naofumi
    Amuro, Hideki
    Hashimoto, Motomu
    Hara, Ryota
    Katayama, Masaki
    Okano, Tadashi
    Kuroda, Ryosuke
    RHEUMATOLOGY, 2023, 63 (11) : 3033 - 3041
  • [29] Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis
    Nash, Peter
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (06) : 44 - 47
  • [30] Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition
    Dowty, Martin E.
    Lin, Tsung H.
    Jesson, Michael I.
    Hegen, Martin
    Martin, David A.
    Katkade, Vaibhav
    Menon, Sujatha
    Telliez, Jean-Baptiste
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (06):
12345